Evidence map›Paper›PMID 34830509›Full record

ArticleJournal of clinical medicine2021

Clinical and Dietary Determinants of Muscle Mass in Patients with Type 2 Diabetes: Data from the Diabetes and Lifestyle Cohort Twente.

Annis C Jalving, Milou M Oosterwijk, Ilse J M Hagedoorn, Gerjan Navis, Stephan J L Bakker, Gozewijn D Laverman

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Annis C JalvingDepartment of Internal Medicine/Nephrology, ZGT Hospital, 7609 PP Almelo, The Netherlands.ORCID 0000-0003-3650-2072
Milou M OosterwijkDepartment of Internal Medicine/Nephrology, ZGT Hospital, 7609 PP Almelo, The Netherlands.ORCID 0000-0002-3256-0630
Ilse J M HagedoornDepartment of Internal Medicine/Nephrology, ZGT Hospital, 7609 PP Almelo, The Netherlands.
Gerjan NavisDepartment of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Stephan J L BakkerDepartment of Internal Medicine, Division of Nephrology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.ORCID 0000-0003-3356-6791
Gozewijn D LavermanDepartment of Internal Medicine/Nephrology, ZGT Hospital, 7609 PP Almelo, The Netherlands.ORCID 0000-0002-8716-7115
Ziekenhuis Groep Twente · NLUniversity Medical Center Groningen · NL

Funding

Ziekenhuis Groep Twente research fund N/A
6 · The paper itself

Abstract

Low muscle mass in patients with type 2 diabetes is associated with a progressively higher risk of morbidity and mortality. The aim of this study was to identify modifiable targets for intervention of muscle mass in type 2 diabetes. Cross-sectional analyses were performed in 375 patients of the Diabetes and Lifestyle Cohort Twente-1 study. Muscle mass was estimated by 24 h urinary creatinine excretion rate (CER, mmol/24 h). Patients were divided in sex-stratified tertiles of CER. To study determinants of CER, multivariable linear regression analyses were performed. Protein intake was determined by Maroni formula and by a semi-quantitative Food Frequency Questionnaire. The mean CER was 16.1 ± 4.8 mmol/24 h and 10.9 ± 2.9 mmol/24 h in men and women, respectively. Lower CER was significantly associated with older age (

Indexed as

cohort studydiabetes type 2lifestylemuscle mass

Identifiers

PMID34830509
PMCPMC8623198
OpenAlexW3213153927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.